Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001240122-25-000006

Director sold 50,000 shares at $70.00 ($3,500,000)

  • Director acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GREY MICHAEL G · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-21 Exercise or conversion : show line 1 in the form 10b5-1 +50,000 $2.94 $146,800 50,000 D
2025-11-21 Sale : show line 2 in the form 10b5-1 −50,000 $70.00 $3,500,000 0 D
Open-market sales · 50,000 sh · avg $70.00 · $3,500,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-21 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −50,000 281,176 D
Loading xslF345X05/form4-11252025_041104.xml…